Abstract
The unique sensitivity of the brain to perturbations in the human genome has been recognized since the early days of karyotyping when it was clear that developmental delay/intellectual disability (DD/ID) was by far the most common phenotypic manifestation of virtually all major chromosomal aberrations. Unlike many biochemical abnormalities that were erroneously linked to DD/ID due to ascertainment bias, the causal link between chromosomal aberrations and DD/ID was robust even in unbiased antenatally ascertained cases. With the advent of modern molecular karyotyping, which is orders of magnitude more sensitive than regular and even “high-resolution” karyotype, the same pattern persisted and DD/ID remains the most common phenotypic expression of the ensuing list of ever smaller genomic rearrangements. Even at the level of single gene mutations, DD/ID is a major phenotype in the majority of the resulting syndromes. This should not come as a surprise knowing that at least 80% of genes are expressed at some point during development in the brain, a fact that likely reflects the extreme complexity of this organ and, subsequently, its vulnerability to any lesion that perturbs the exquisitely orchestrated network of molecules required for its development and function [1]. Pediatric neurologists, therefore, are at the frontline in the assessment and management of the majority of patients with genetic syndromes, and although there are those who specialize specifically in neurogenetic conditions, all pediatric neurologists should be prepared to provide a first-line assessment of these patients. The goal of this chapter is to provide a pediatric neurologist-friendly strategy to systemically approach patients with suspected neurogenetic phenotypes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hawrylycz MJ, Lein S, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, Van De Lagemaat LN, Smith KA, Ebbert A, Riley ZL. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489:391.
Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, Kwint M, Janssen IM, Hoischen A, Schenck A. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344.
Anazi S, Maddirevula S, Faqeih E, Alsedairy H, Alzahrani F, Shamseldin H, Patel N, Hashem M, Ibrahim N, Abdulwahab F. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Mol Psychiatry. 2017;22:615–24.
Monies D, Abouelhoda M, AlSayed M, Alhassnan Z, Alotaibi M, Kayyali H, Al-Owain M, Shah A, Rahbeeni Z, Al-Muhaizea MA. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet. 2017;136:921–39.
Myers C, Mefford H. Genetic investigations of the epileptic encephalopathies: recent advances. Prog Brain Res. 2016;226:35–60.
Shaheen R, Maddirevula S, Ewida N, et al. Genomic and phenotypic delineation of congenital microcephaly, Genet Med. 2019;21(3):545–52. https://doi.org/10.1038/s41436-018-0140-3. Epub 2018 Sep 14.
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64.
Tan TY, Dillon OJ, Stark Z, Schofield D, Alam K, Shrestha R, Chong B, Phelan D, Brett GR, Creed E. Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatr. 2017;171:855–62.
Monies D, Abouelhoda M, Assoum M, et al. Learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet. 2019;105(4):879. https://doi.org/10.1016/j.ajhg.2019.09.019.
Alkuraya FS. Natural human knockouts and the era of genotype to phenotype. Genome Med. 2015;7:48.
Shamseldin HE, Maddirevula S, Faqeih E, Ibrahim N, Hashem M, Shaheen R, Alkuraya FS. Increasing the sensitivity of clinical exome sequencing through improved filtration strategy. Genet Med. 2016;19:593–8.
Shaheen R, Rahbeeni Z, Alhashem A, Faqeih E, Zhao Q, Xiong Y, Almoisheer A, Al-Qattan SM, Almadani HA, Al-Onazi N. Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH. Am J Hum Genet. 2014;94:898–904.
El-Hattab AW, Shaheen R, Hertecant J, Galadari HI, Albaqawi BS, Nabil A, Alkuraya FS. On the phenotypic spectrum of serine biosynthesis defects. J Inherit Metab Dis. 2016;39:373–81.
Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, Alaiya AA, Rizzo WB, Alkuraya FS. Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am J Hum Genet. 2011;89:745–50.
Alkuraya FS, Shaheen R. Variable phenotypic expression of COG6 mutations. J Med Genet. 2014;51:425–6.
Shaheen R, Ansari S, Alshammari MJ, Alkhalidi H, Alrukban H, Eyaid W, Alkuraya FS. A novel syndrome of hypohidrosis and intellectual disability is linked to COG6 deficiency. J Med Genet. 2013;50:431–6.
Shaheen R, Sebai MA, Patel N, Ewida N, Kurdi W, Altweijri I, Sogaty S, Almardawi E, Seidahmed MZ, Alnemri A. The genetic landscape of familial congenital hydrocephalus. Ann Neurol. 2017;81:890–7.
Vissers LE, van Nimwegen KJ, Schieving JH, Kamsteeg E-J, Kleefstra T, Yntema HG, Pfundt R, van der Wilt GJ, Krabbenborg L, Brunner HG. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet Med. 2017;19:1055–63.
Alkuraya F. Impact of new genomic tools on the practice of clinical genetics in consanguineous populations: the Saudi experience. Clin Genet. 2013;84:203–8.
Alkuraya FS. Genetics and genomic medicine in Saudi Arabia. Mol Genet Genom Med. 2014;2:369–78.
Ashour ME, Atteya R, El-Khamisy SF. Topoisomerase-mediated chromosomal break repair: an emerging player in many games. Nat Rev Cancer. 2015;15:137.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alkuraya, F.S. (2020). A Diagnostic Approach for Neurogenetic Disorders in the Genome Era. In: Salih, M.A. (eds) Clinical Child Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-43153-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-43153-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43152-9
Online ISBN: 978-3-319-43153-6
eBook Packages: MedicineMedicine (R0)